Clinical Trial Update: Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab in combination with cetuximab and chemotherapy for conversion therapy in locally nonresectable oral cavity squamous cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• Cetuximab (cetuximab)
• Toripalimab (Toripalimab)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: UNKNOWN